郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Pharmaceutical Characterization of Tropomyosin Receptor Kinase B-Agonistic Antibodies on Human Induced Pluripotent Stem (hiPS) Cell-Derived Neurons.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2017作者：Stefanie Traub; Heiko Stahl; Holger Rosenbrock; Eric Simon; Lore Florin; Lisa Hospach; Stefan Hörer; Ralf Heilker
阅读更多 →

药效评价ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesis.

期刊：Atherosclerosis发表年份：2017作者：Anouar Hafiane; Jacques Genest
阅读更多 →

药效评价Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2017作者：Dimitri E Grigoriadis; Evan Smith; Sam R J Hoare; Ajay Madan; Haig Bozigian
阅读更多 →

药效评价Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low β-Arrestin Recruitment and Desensitization Potential.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2017作者：John Gatfield; Katalin Menyhart; Daniel Wanner; Carmela Gnerre; Lucile Monnier; Keith Morrison; Patrick Hess; Marc Iglarz; Martine Clozel; Oliver Nayler
阅读更多 →